We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$14.1B
1-Year Est. Return
30.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+30.11%
3 Year Est. Return
+110.39%
5 Year Est. Return
+152.15%
10 Year Est. Return
+370.53%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
SOLS
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.63% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TDAY
1576
USA Today Co
TDAY
$1.24B
| $96.5K | ﹤0.01% |
13,681
+1,691
| +14% | +$10.4K |
|
1577
Nuvation Bio
NUVB
$2.18B
| $94.5K | ﹤0.01% |
22,035
+3,079
| +16% | +$17.2K |
|
1578
United States Antimony
UAMY
$794M
| $94.2K | ﹤0.01% |
+10,793
| New | +$94.1K |
|
1579
Harmonic Inc
HLIT
$1.31B
| $92K | ﹤0.01% |
+10,243
| New | +$102K |
|
1580
Bitdeer Technologies
BTDR
$2.77B
| $90.3K | ﹤0.01% |
+10,441
| New | +$110K |
|
1581
Taysha Gene Therapies
TSHA
$1.6B
| $89.5K | ﹤0.01% |
20,033
+2,815
| +16% | +$13.1K |
|
1582
Wave Life Sciences
WVE
$1.1B
| $89.2K | ﹤0.01% |
+12,303
| New | +$160K |
|
1583
Genius Sports
GENI
$1.8B
| $87.8K | ﹤0.01% |
19,817
+2,793
| +16% | +$19.9K |
|
1584
Enovix
ENVX
$997M
| $87.8K | ﹤0.01% |
16,942
+3,810
| +29% | +$23.8K |
|
1585
Teladoc Health
TDOC
$1.74B
| $87.5K | ﹤0.01% |
16,053
+1,865
| +13% | +$10.5K |
|
1586
NeoGenomics
NEO
$1.85B
| $87.3K | ﹤0.01% |
11,764
+1,647
| +16% | +$17.3K |
|
1587
RLJ Lodging Trust
RLJ
$1.82B
| $85.9K | ﹤0.01% |
11,571
+801
| +7% | +$6.23K |
|
1588
Biohaven
BHVN
$2.24B
| $85.2K | ﹤0.01% |
+10,069
| New | +$110K |
|
1589
Coty
COTY
$2.38B
| $85K | ﹤0.01% |
42,288
+7,286
| +21% | +$19.6K |
|
|
PDM
1590
Piedmont Realty Trust
PDM
$1.21B
| $84.1K | ﹤0.01% |
12,795
+1,491
| +13% | +$11.6K |
|
1591
Evolv Technologies
EVLV
$1.01B
| $83.8K | ﹤0.01% |
13,846
+1,862
| +16% | +$10.9K |
|
1592
Burford Capital
BUR
$881M
| $83.4K | ﹤0.01% |
18,454
+2,646
| +17% | +$23.1K |
|
1593
Xeris Biopharma Holdings
XERS
$1.48B
| $83.1K | ﹤0.01% |
14,325
+2,213
| +18% | +$14.7K |
|
1594
NCR Voyix
VYX
$1.11B
| $80.3K | ﹤0.01% |
12,693
+1,628
| +15% | +$14.4K |
|
1595
Capitol Federal Financial
CFFN
$1.06B
| $79.7K | ﹤0.01% |
+11,173
| New | +$79.6K |
|
1596
Acco Brands
ACCO
$372M
| $79.1K | ﹤0.01% |
26,383
+1,048
| +4% | +$3.95K |
|
1597
Under Armour
UAA
$3.1B
| $78.9K | ﹤0.01% |
+13,345
| New | +$86.5K |
|
1598
Under Armour Class C
UA
$3.04B
| $76.1K | ﹤0.01% |
+13,140
| New | +$82.9K |
|
1599
Coursera
COUR
$1.56B
| $74.9K | ﹤0.01% |
12,862
+1,631
| +15% | +$10.2K |
|
|
TE
1600
T1 Energy
TE
$1.68B
| $73.9K | ﹤0.01% |
16,839
+6,474
| +62% | +$47.4K |
|
Similar funds
CM
ETC
BIP
FGP
BPC
SSA
TI
BBVA
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.